Max Masucci
Stock Analyst at Roth MKM
(3.94)
# 1,809
Out of 4,534 analysts
159
Total ratings
41.9%
Success rate
8.5%
Average return
Main Sectors:
Stocks Rated by Max Masucci
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CSTL Castle Biosciences | Initiated Coverage: Buy | $94 → $40 | $23.90 | +67.40% | 19 | Jun 25, 2026 | |
| XGN Exagen | Initiated Coverage: Buy | $16 → $8 | $4.68 | +70.94% | 4 | Jun 25, 2026 | |
| BDSX Biodesix | Initiated Coverage: Buy | $32 | $19.81 | +61.53% | 8 | Jun 25, 2026 | |
| BLFS BioLife Solutions | Maintained: Buy | $29 → $25 | $29.09 | n/a | 5 | Aug 9, 2023 | |
| BRKR Bruker | Maintained: Hold | $75 → $79 | $56.17 | n/a | 4 | Aug 4, 2023 | |
| RVTY Revvity | Maintained: Buy | $155 → $151 | $106.44 | n/a | 5 | Aug 2, 2023 | |
| GH Guardant Health | Maintained: Buy | $70 → $53 | $148.07 | n/a | 18 | Feb 24, 2023 | |
| CTKB Cytek Biosciences | Reiterated: Buy | $17 | $4.58 | n/a | 2 | Dec 13, 2022 | |
| WGS GeneDx Holdings | Maintained: Buy | $5 → $99 | $60.65 | n/a | 3 | Nov 15, 2022 | |
| TKNO Alpha Teknova | Maintained: Buy | $13 → $8 | $5.30 | n/a | 4 | Nov 10, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $18 → $15 | $3.90 | n/a | 24 | Nov 9, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $13.34 | n/a | 2 | Nov 3, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $10.07 | n/a | 2 | Sep 8, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $1.17 | n/a | 2 | Jun 23, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $110 → $100 | $262.63 | n/a | 22 | May 6, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $28 | $1.98 | n/a | 1 | Nov 29, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $32 → $39 | $2.21 | n/a | 2 | Nov 5, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | n/a | $1.69 | n/a | 1 | Nov 2, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $7.03 | n/a | 1 | Oct 14, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $2.07 | n/a | 1 | Oct 14, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $8.16 | n/a | 1 | Oct 14, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $470 → $515 | $184.68 | n/a | 16 | Jul 14, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $3.5 | $0.0009 | n/a | 11 | May 6, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $0.25 | $0.01 | n/a | 1 | Apr 2, 2020 |
Castle Biosciences
Jun 25, 2026
Initiated Coverage: Buy
Price Target: $94 → $40
Current: $23.90
Upside: +67.40%
Exagen
Jun 25, 2026
Initiated Coverage: Buy
Price Target: $16 → $8
Current: $4.68
Upside: +70.94%
Biodesix
Jun 25, 2026
Initiated Coverage: Buy
Price Target: $32
Current: $19.81
Upside: +61.53%
BioLife Solutions
Aug 9, 2023
Maintained: Buy
Price Target: $29 → $25
Current: $29.09
Upside: n/a
Bruker
Aug 4, 2023
Maintained: Hold
Price Target: $75 → $79
Current: $56.17
Upside: n/a
Revvity
Aug 2, 2023
Maintained: Buy
Price Target: $155 → $151
Current: $106.44
Upside: n/a
Guardant Health
Feb 24, 2023
Maintained: Buy
Price Target: $70 → $53
Current: $148.07
Upside: n/a
Cytek Biosciences
Dec 13, 2022
Reiterated: Buy
Price Target: $17
Current: $4.58
Upside: n/a
GeneDx Holdings
Nov 15, 2022
Maintained: Buy
Price Target: $5 → $99
Current: $60.65
Upside: n/a
Alpha Teknova
Nov 10, 2022
Maintained: Buy
Price Target: $13 → $8
Current: $5.30
Upside: n/a
Nov 9, 2022
Maintained: Hold
Price Target: $18 → $15
Current: $3.90
Upside: n/a
Nov 3, 2022
Reiterated: Buy
Price Target: n/a
Current: $13.34
Upside: n/a
Sep 8, 2022
Reiterated: Buy
Price Target: n/a
Current: $10.07
Upside: n/a
Jun 23, 2022
Reiterated: Buy
Price Target: n/a
Current: $1.17
Upside: n/a
May 6, 2022
Maintained: Buy
Price Target: $110 → $100
Current: $262.63
Upside: n/a
Nov 29, 2021
Initiated Coverage: Buy
Price Target: $28
Current: $1.98
Upside: n/a
Nov 5, 2021
Maintained: Buy
Price Target: $32 → $39
Current: $2.21
Upside: n/a
Nov 2, 2021
Initiated Coverage: Buy
Price Target: n/a
Current: $1.69
Upside: n/a
Oct 14, 2021
Maintained: Buy
Price Target: n/a
Current: $7.03
Upside: n/a
Oct 14, 2021
Maintained: Buy
Price Target: n/a
Current: $2.07
Upside: n/a
Oct 14, 2021
Maintained: Hold
Price Target: n/a
Current: $8.16
Upside: n/a
Jul 14, 2021
Maintained: Buy
Price Target: $470 → $515
Current: $184.68
Upside: n/a
May 6, 2021
Maintained: Buy
Price Target: $3.5
Current: $0.0009
Upside: n/a
Apr 2, 2020
Initiated Coverage: Buy
Price Target: $0.25
Current: $0.01
Upside: n/a